These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38878755)

  • 1. Structure-activity relationships of natural and synthetic lathyrane-based diterpenoids for suppression of NLRP3-driven inflammation and gouty arthritis.
    Zhuang Y; Pan B; Zhang Y; Tang Z; Ji X; Zhang S; Yao L; Li T; Ma W; Tan C; Luo Y
    Bioorg Chem; 2024 Sep; 150():107558. PubMed ID: 38878755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euphorbia factor L2 alleviated gouty inflammation by specifically suppressing both the priming and activation of NLRP3 inflammasome.
    Li Y; Zhuang Y; Chen Y; Wang G; Tang Z; Zhong Y; Zhang Y; Wu L; Ji X; Zhang Q; Pan B; Luo Y
    Int Immunopharmacol; 2024 Sep; 138():112598. PubMed ID: 38981223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of New Lathyrane Diterpenoid Derivatives from Euphorbia lathyris and Evaluation of Their Anti-Inflammatory Activities.
    Wang W; Wu Y; Li C; Yang Y; Li X; Li H; Chen L
    Chem Biodivers; 2020 Feb; 17(2):e1900531. PubMed ID: 31825561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy.
    Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M
    Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of lathyrane diterpenoid nitrogen-containing heterocyclic derivatives and evaluation of their anti-inflammatory activities.
    Wang W; Xiong L; Li Y; Song Z; Sun D; Li H; Chen L
    Bioorg Med Chem; 2022 Feb; 56():116627. PubMed ID: 35063896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
    Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR
    Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory Lathyrane Diterpenoids from Euphorbia lathyris.
    Zhang CY; Wu YL; Zhang P; Chen ZZ; Li H; Chen LX
    J Nat Prod; 2019 Apr; 82(4):756-764. PubMed ID: 30817151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing lathyrane structural diversity and MDR activity by combinatorial modification of lathyrane nucleus and ester side chain: A case study of Euphorbia Factor L1 and Euphorbia Factor L3.
    Zhan Z; Liu X; Cheng Z
    Fitoterapia; 2024 Apr; 174():105854. PubMed ID: 38331050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate attenuates MSU-induced gouty arthritis by inhibiting NLRP3 inflammasome activation and oxidative stress.
    Cao Y; Hu Y; Jin XF; Liu Y; Zou JM
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):628-641. PubMed ID: 36734707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity.
    He C; Liu J; Li J; Wu H; Jiao C; Ze X; Xu S; Zhu Z; Guo W; Xu J; Yao H
    J Med Chem; 2024 Jun; 67(11):9406-9430. PubMed ID: 38751194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diterpenoids from the seeds of Euphorbia lathyris and their anti-inflammatory activity.
    Wang Y; Song Z; Guo Y; Xie H; Zhang Z; Sun D; Li H; Chen L
    Bioorg Chem; 2021 Jul; 112():104944. PubMed ID: 33962090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
    Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
    Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
    Zhou M; Li S; Song L; Hu Q; Liu W
    Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
    Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
    J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu Y; Miao TW; Xiao W; Mao B; Du LY; Wang Y; Fu JJ
    Drug Des Devel Ther; 2024; 18():1755-1770. PubMed ID: 38808326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis.
    Marchetti C; Swartzwelter B; Koenders MI; Azam T; Tengesdal IW; Powers N; de Graaf DM; Dinarello CA; Joosten LAB
    Arthritis Res Ther; 2018 Aug; 20(1):169. PubMed ID: 30075804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leojaponin inhibits NLRP3 inflammasome activation through restoration of autophagy via upregulating RAPTOR phosphorylation.
    Zhang XJ; Shang K; Pu YK; Wang Q; Wang TT; Zou Y; Wang YM; Xu YJ; Li XL; Zhang RH; Xiao WL
    J Ethnopharmacol; 2021 Oct; 278():114322. PubMed ID: 34118343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
    Yang G; Yeon SH; Lee HE; Kang HC; Cho YY; Lee HS; Lee JY
    Rheumatology (Oxford); 2018 Apr; 57(4):727-736. PubMed ID: 29340626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice.
    Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L
    J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways.
    Cheng JJ; Ma XD; Ai GX; Yu QX; Chen XY; Yan F; Li YC; Xie JH; Su ZR; Xie QF
    Drug Des Devel Ther; 2022; 16():2119-2132. PubMed ID: 35812134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.